Shigella species and enteroinvasive strains of Escherichia coli (EIEC) cause disease by invading and multiplying within the colonic epithelial cells. While isolation and identification of shigellae from clinical isolates is a routine matter, this is not the case for EIEC. Identification of these organisms by biochemical tests is not possible, and many isolates belonging to recognized EIEC serogroups are avirulent (11, 12, 14) . Therefore, diagnostic tests employing DNA probes or erizyme-linked immunosorbent assay (ELISA) have been designed to allow identification of enteroinvasive pathogens. The latter assay uses hyperimmune rabbit antiserum raised against an EIEC strain of serogroup 0143 and absorbed with an isogenic avirulent mutant of the same serogroup (11, 12) . The cross-reacting antigenic moiety recognized by this serum was designated the virulence marker antigen (VMA) (11) . The VMA ELISA successfully identified 83 virulent strains of Shigella species and EIEC (12) , and the assay differentiated EIEC that were isolated from children with dysentery in Thailand (14) . Avirulent strains of Shigella species and of EIEC serogroups were negative in the VMA ELISA (9) .
Although the VMA ELISA proved to be a useful diagnostic tool, the nature of VMA was unclear (11) . DNA probes recognizing portions of the 140-megadalton (MDa) plasmids which are necessary for virulence in EIEC and in Shigella flexneri (5, 13) have successfully identified enteroinvasive organisms (1, 14, 15) , so it seemed likely that the virulence plasmids might encode cross-reacting antigen(s) such as VMA (12) . Arguing against this hypothesis was the fact that the avirulent EIEC mutant (strain 2/33), which was used to absorb the VMA rabbit serum, retains the 140-MDa plasmid (11) . However, it has recently been shown that VMA reactivity is transferred with the 140-MDa plasmid (10) , and this finding strongly suggests that the VMA is plasmid encoded.
Since antibody recognizing four plasmid-encoded proteins of S. flexneri has been shown to cross-react with similar proteins in Western blots (immunoblots) using other Shigella species and EIEC 0143 (4), we considered it likely that one or more of these proteins might constitute the VMA. Western blot analysis of convalescent-stage serum from monkeys or humans has shown that these plasmid-encoded proteins are the immunodominant antigens in the event of a Shigella infection (8) . Therefore, these proteins have been designated ''invasion plasmid antigens," and the plasmid locus encoding them has been designated the ipa locus (2) . Figure 1 shows the results of a Western blot of the E. coli 0143 strain which was used in the manufacture of VMA serum (lane A) and the avirulent derivative of this strain which was used to absorb the VMA serum (lane B). This immunoblot was developed with serum from a monkey which had been infected with S. flexneri 2a for 2 weeks before being bled. As expected, the convalescent-stage monkey serum recognized four proteins in the virulent EIEC strain which were not present in the avirulent mutant. These proteins are ipa gene products which have been designated IpaA (78 kDa), IpaB (62 kDa), IpaC (43 kDa), and IpaD (38 kDa) (7) . In addition to these constituents, a 140-kDa plasmid-encoded protein (3, 8) was recognized in both strains. In contrast to its expression of the ipa gene products, the avirulent mutant apparently expresses wild-type levels of this protein.
Since Fig. 1 indicates that virulent EIEC 0143 strain 2 expresses ipa gene products and avirulent strain 2/33 does not, it is possible that rabbit antiserum raised against the former strain would contain anti-ipa antibody which could not be absorbed by the latter strain. For Fig. 2 (Fig. 3, lane 2) , S.flexneri (lanes 4, 5, and 10), and Shigella dysenteriae (lane 11). In contrast, plasmid-negative strains of S. sonnei (lane 1) and S. flexneri (lane 7 and 9) were not recognized by the VMA serum. An avirulent colonial variant of S. flexneri 2a (strain 2457-0, lane 6) also did not express the ipa proteins. Like the 2/33 EIEC strain, this strain carries the 140-MDa plasmid (6) . This indicates that occasional avirulent strains of Shigella or EIEC may fail to express the ipa gene products even through they retain the invasion plasmid. Nonetheless, previous VMA ELISA results indicate that such VMA-negative, plasmid-positive strains are not usually found among clinical isolates (14) .
In summary, Western blot analysis indicates that the VMA ELISA specifically recognizes proteins which are encoded by invasion plasmids of EIEC and Shigella species. Although the role of these proteins in the pathogenesis of enteroinvasive disease is unknown, there are presently no examples of enteroinvasive strains which do not express these products. Therefore 
